首页|苏黄止咳胶囊联合复方甲氧那明胶囊治疗急性上呼吸道感染后咳嗽的效果

苏黄止咳胶囊联合复方甲氧那明胶囊治疗急性上呼吸道感染后咳嗽的效果

扫码查看
目的:观察苏黄止咳胶囊联合复方甲氧那明胶囊治疗急性上呼吸道感染后咳嗽患者的效果.方法:选取 2022 年 2 月至2023 年 3 月该院收治的 120 例急性上呼吸道感染后咳嗽患者进行前瞻性研究,按照随机数字表法分为研究组与对照组各 60 例.对照组采用复方甲氧那明胶囊治疗,研究组在对照组基础上联合苏黄止咳胶囊治疗,比较两组临床疗效、咳嗽症状积分表评分、莱切斯特咳嗽问卷(LCQ)评分、血清炎性指标[C反应蛋白(CRP)和降钙素原]水平和不良反应发生率.结果:研究组治疗总有效率为 91.67%,高于对照组的 73.33%,差异有统计学意义(P<0.05);治疗后,两组咳嗽症状积分表日间和夜间积分以及血清CRP、降钙素原水平均低于治疗前,且研究组低于对照组,两组LCQ评分均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:苏黄止咳胶囊联合复方甲氧那明胶囊治疗急性上呼吸道感染后咳嗽可提高治疗总有效率和LCQ评分,降低咳嗽症状积分表日间、夜间积分以及血清CRP、降钙素原水平,效果优于单纯复方甲氧那明胶囊治疗.
Effects of Suhuang Zhike capsules combined with compound Methoxyphenamine capsules in treatment of cough after acute upper respiratory tract infection
Objective:To observe effects of Suhuang Zhike capsules combined with compound Methoxyphenamine capsules in treatment of cough after acute upper respiratory tract infection.Methods:A prospective study was conducted on 120 patients with cough after acute upper respiratory tract infection admitted to the hospital from February 2022 to March 2023.According to the random number table method,they were divided into study group and control group,60 cases in each group.The control group was treated with compound Methoxyphenamine capsules,while the study group was treated with Suhuang Zhike capsules on the basis of that of the control group.The clinical efficacy,the cough symptom score,the Leicester cough questionnaire(LCQ)score,the serum inflammatory indexes[C-reactive protein(CRP)and procalcitonin]levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 91.67%,which was higher than 73.33%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the daytime and nighttime scores of cough symptom scores as well as the serum CRP and procalcitonin levels in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;the LCQ scores of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Suhuang Zhike capsules combined with compound Methoxyphenamine capsule in the treatment of cough after acute upper respiratory tract infection can improve the total effective rate of treatment and the LCQ score,reduce the daytime and nighttime scores of cough symptom score and the serum CRP and procalcitonin levels.Moreover,it is superior to single compound Methoxyphenamine capsules treatment.

Suhuang Zhike capsulesCompound Methoxyphenamine capsulesAcute upper respiratory tract infection

王聪、乔瑞晗、王骁亚

展开 >

南阳市第一人民医院呼吸重症监护室,河南 南阳 473000

苏黄止咳胶囊 复方甲氧那明胶囊 急性上呼吸道感染

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(6)
  • 15